Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Poole
Kenneth E S
KE
Warburton
Elizabeth A
EA
Reeve
Jonathan
J
D000058:Accidental Falls / Q000706:statistics & numerical data; D000368:Aged; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015984:Causality; D002986:Clinical Trials as Topic / Q000592:standards; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006620:Hip Fractures / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D018579:Patient Selection; D011859:Radiography; D015203:Reproducibility of Results; D000068296:Risedronic Acid; D015983:Selection Bias; D016103:Spinal Fractures / Q000000981:diagnostic imaging / Q000453:epidemiology; D020521:Stroke / Q000150:complications*
D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid